31 Parc du Golf - CS 90519
13593 Aix en Provence - FRANCE Website

Key figures

Creation date : 2012
Number of employees : 8
Investment date : Mérieux Participations 2
Fund name : MérieuxParticipations 2

Company presentation

PhysioAssist has developed a unique expertise in bronchial mucus analysis and clearance. PhysioAssist’s unique model of digital simulation allowed a detailed analysis of the impact of vibrational signals on human mucus in the distant airways of the bronchi. The stagnation of mucus in these areas is often considered to be a root cause of pulmonary infections. Patients with obstructive pathologies have to clear their airways on a daily basis.

PhysioAssist’s lead product, Simeox™, delivers a simple solution to clear airways efficiently, particularly suited for COPD and Cystic Fibrosis patients.

It is currently commercialized in France and some countries within Western Europe.

A session of treatment with Simeox™ typically lasts for 10 to 20 minutes and is supervised by  healthcare professional, and can eventually be provided at home, to improve quality of life and patient compliance.

Product and service

.